首页> 外文OA文献 >Treatment for acute anterior cruciate ligament tear: five year outcome of randomised trial. : Five year outcome of randomised trial
【2h】

Treatment for acute anterior cruciate ligament tear: five year outcome of randomised trial. : Five year outcome of randomised trial

机译:急性前交叉韧带撕裂的治疗:随机试验的五年结果。 :随机试验的五年结果

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Objective To compare, in young active adults with an acute anterior cruciate ligament (ACL) tear, the mid-term (five year) patient reported and radiographic outcomes between those treated with rehabilitation plus early ACL reconstruction and those treated with rehabilitation and optional delayed ACL reconstruction. Design Extended follow-up of prospective randomised controlled trial. Setting Orthopaedic departments at two hospitals in Sweden. Participants 121 young, active adults (mean age 26 years) with acute ACL injury to a previously uninjured knee. One patient was lost to five year follow-up. Intervention All patients received similar structured rehabilitation. In addition to rehabilitation, 62 patients were assigned to early ACL reconstruction and 59 were assigned to the option of having a delayed ACL reconstruction if needed. Main outcome measure The main outcome was the change from baseline to five years in the mean value of four of the five subscales of the knee injury and osteoarthritis outcome score (KOOS4). Other outcomes included the absolute KOOS4 score, all five KOOS subscale scores, SF-36, Tegner activity scale, meniscal surgery, and radiographic osteoarthritis at five years. Results Thirty (51%) patients assigned to optional delayed ACL reconstruction had delayed ACL reconstruction (seven between two and five years). The mean change in KOOS4 score from baseline to five years was 42.9 points for those assigned to rehabilitation plus early ACL reconstruction and 44.9 for those assigned to rehabilitation plus optional delayed reconstruction (between group difference 2.0 points, 95% confidence interval -8.5 to 4.5; P=0.54 after adjustment for baseline score). At five years, no significant between group differences were seen in KOOS4 (P=0.45), any of the KOOS subscales (P≥0.12), SF-36 (P≥0.34), Tegner activity scale (P=0.74), or incident radiographic osteoarthritis of the index knee (P=0.17). No between group differences were seen in the number of knees having meniscus surgery (P=0.48) or in a time to event analysis of the proportion of meniscuses operated on (P=0.77). The results were similar when analysed by treatment actually received. Conclusion In this first high quality randomised controlled trial with minimal loss to follow-up, a strategy of rehabilitation plus early ACL reconstruction did not provide better results at five years than a strategy of initial rehabilitation with the option of having a later ACL reconstruction. Results did not differ between knees surgically reconstructed early or late and those treated with rehabilitation alone. These results should encourage clinicians and young active adult patients to consider rehabilitation as a primary treatment option after an acute ACL tear.
机译:目的比较在急性前交叉韧带(ACL)撕裂的年轻活跃成年人中,报告的中期(五年)患者和影像学结果与接受康复加早期ACL重建治疗的患者以及接受康复和选择性延迟ACL的患者之间的比较重建。设计前瞻性随机对照试验的扩展随访。在瑞典的两家医院设置骨科。参与者121名先前未受伤的膝盖遭受急性ACL损伤的活跃年轻人(平均年龄26岁)。一名患者失去了五年的随访。干预所有患者均接受了类似的结构化康复。除康复外,如果需要,将62例患者分配为早期ACL重建,将59例患者分配为延迟进行ACL重建。主要结局指标主要结局指标是膝关节损伤和骨关节炎结局评分(KOOS4)的五个子量表中四个分量表的平均值从基线到五年的变化。其他结果包括5年时的KOOS4绝对评分,全部5个KOOS分量表评分,SF-36,Tegner活动量表,半月板手术和X线骨关节炎。结果30例(51%)患者被要求进行选择性ACL延迟重建,其ACL重建延迟(在2至5年间为7)。从基线到五年,KOOS4评分从基线到五年的平均变化对于那些被分配到康复加早期ACL的患者来说是42.9分,对于那些被分配给康复加可选的延迟重建的患者是44.9点(组间差异2.0分,95%的置信区间-8.5至4.5;调整基线分数后,P = 0.54)。五年后,在KOOS4(P = 0.45),任何KOOS分量表(P≥0.12),SF-36(P≥0.34),Tegner活动量表(P = 0.74)或事件中均未发现组间差异。膝关节影像学骨关节炎(P = 0.17)。在进行半月板手术的膝盖数(P = 0.48)或进行手术的半月板手术比例的事件分析中(P = 0.77),两组之间均无差异。通过实际接受的治疗分析,结果相似。结论在第一项高质量,无随访损失的高质量随机对照试验中,康复加早期ACL重建的策略在5年内没有提供比初始康复策略和以后再进行ACL重建的策略更好的结果。早期或晚期通过手术重建的膝盖与仅接受康复治疗的膝盖之间的结果没有差异。这些结果应鼓励临床医生和活跃的年轻成年患者在急性ACL撕裂后将康复作为主要治疗选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号